Minnesota HF 753: Price gouging prohibited; Board of Pharmacy, commissioner of human services, and health plan companies allowed to notify the attorney general of prescription drug price increases; attorney general authorized to obtain drug pricing information and take action against manufacturers and wholesalers for price increases; and civil penalties imposed.

Status: Author added Brand (as of 2019-04-26)

State: Minnesota · Session: 2019-2020 · Bill: HF 753

Subjects: Drugs and Medicine, Health and Health Department, State Boards

Sponsors: Mahoney, Bernardy, Bierman, Brand, Carlson, L., Edelson, Elkins, Moller, Sandstede

View Minnesota HF 753 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.